Hepatocellular Carcinoma

A Decade of Hospitalizations and Financial Burden in the United States

Raxitkumar Jinjuvadia, Augustine Salami, Adrienne Lenhart, Kartikkumar Jinjuvadia, Suthat Liangpunsakul, Reena Salgia

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

BACKGROUND: Despite a rise in the prevalence of hepatocellular carcinoma (HCC), data on HCC-related hospitalizations and financial burden are limited. The aim of this study was to evaluate temporal trends of HCC-related hospitalizations and evaluate its financial influence.

MATERIALS AND METHODS: Patients with the diagnosis of HCC, as reported by International Classification of Diseases-Ninth Revision code, were identified from the National Inpatient Sample databases from 2002-2011. The national estimates of hospitalizations were derived using appropriate sample weights. The change in total average charges per each hospitalization over the study period was calculated after adjusting for inflation.

RESULTS: Hospitalizations related to HCC have increased from 24,024 in 2002 to 50,609 in 2011. Of these admissions, HCC was the principal diagnosis in 10,762 and 16,350 subjects in 2002 and 2011, respectively. Most were white males (male: 70%; white: 55%). The overall inpatient mortality was significantly decreased from 13.5% in 2002 to 9.9% in 2011 (P < 0.01). The same trend was also observed for the length of hospital stay (6.5 versus 5.6 days in 2002 and 2011, respectively). The inflation-adjusted cost per hospitalization increased by approximately 47% during the study period.

CONCLUSIONS: Despite the decrease in mortality rate and length-of-stay, hospitalizations and financial burden associated with HCC continued to increase between 2002 and 2011 in the United States.

Original languageEnglish (US)
Pages (from-to)362-369
Number of pages8
JournalThe American journal of the medical sciences
Volume354
Issue number4
DOIs
StatePublished - Oct 1 2017

Fingerprint

Hepatocellular Carcinoma
Hospitalization
Length of Stay
Economic Inflation
Inpatients
Mortality
International Classification of Diseases
Databases
Weights and Measures
Costs and Cost Analysis

Keywords

  • Financial burden
  • Hepatocellular carcinoma
  • Hospitalizations
  • Liver cancer
  • National Inpatient Sample database

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Hepatocellular Carcinoma : A Decade of Hospitalizations and Financial Burden in the United States. / Jinjuvadia, Raxitkumar; Salami, Augustine; Lenhart, Adrienne; Jinjuvadia, Kartikkumar; Liangpunsakul, Suthat; Salgia, Reena.

In: The American journal of the medical sciences, Vol. 354, No. 4, 01.10.2017, p. 362-369.

Research output: Contribution to journalArticle

Jinjuvadia, Raxitkumar ; Salami, Augustine ; Lenhart, Adrienne ; Jinjuvadia, Kartikkumar ; Liangpunsakul, Suthat ; Salgia, Reena. / Hepatocellular Carcinoma : A Decade of Hospitalizations and Financial Burden in the United States. In: The American journal of the medical sciences. 2017 ; Vol. 354, No. 4. pp. 362-369.
@article{9439d097a4f341c1a3f4255b89b4745b,
title = "Hepatocellular Carcinoma: A Decade of Hospitalizations and Financial Burden in the United States",
abstract = "BACKGROUND: Despite a rise in the prevalence of hepatocellular carcinoma (HCC), data on HCC-related hospitalizations and financial burden are limited. The aim of this study was to evaluate temporal trends of HCC-related hospitalizations and evaluate its financial influence.MATERIALS AND METHODS: Patients with the diagnosis of HCC, as reported by International Classification of Diseases-Ninth Revision code, were identified from the National Inpatient Sample databases from 2002-2011. The national estimates of hospitalizations were derived using appropriate sample weights. The change in total average charges per each hospitalization over the study period was calculated after adjusting for inflation.RESULTS: Hospitalizations related to HCC have increased from 24,024 in 2002 to 50,609 in 2011. Of these admissions, HCC was the principal diagnosis in 10,762 and 16,350 subjects in 2002 and 2011, respectively. Most were white males (male: 70{\%}; white: 55{\%}). The overall inpatient mortality was significantly decreased from 13.5{\%} in 2002 to 9.9{\%} in 2011 (P < 0.01). The same trend was also observed for the length of hospital stay (6.5 versus 5.6 days in 2002 and 2011, respectively). The inflation-adjusted cost per hospitalization increased by approximately 47{\%} during the study period.CONCLUSIONS: Despite the decrease in mortality rate and length-of-stay, hospitalizations and financial burden associated with HCC continued to increase between 2002 and 2011 in the United States.",
keywords = "Financial burden, Hepatocellular carcinoma, Hospitalizations, Liver cancer, National Inpatient Sample database",
author = "Raxitkumar Jinjuvadia and Augustine Salami and Adrienne Lenhart and Kartikkumar Jinjuvadia and Suthat Liangpunsakul and Reena Salgia",
year = "2017",
month = "10",
day = "1",
doi = "10.1016/j.amjms.2017.05.016",
language = "English (US)",
volume = "354",
pages = "362--369",
journal = "American Journal of the Medical Sciences",
issn = "0002-9629",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Hepatocellular Carcinoma

T2 - A Decade of Hospitalizations and Financial Burden in the United States

AU - Jinjuvadia, Raxitkumar

AU - Salami, Augustine

AU - Lenhart, Adrienne

AU - Jinjuvadia, Kartikkumar

AU - Liangpunsakul, Suthat

AU - Salgia, Reena

PY - 2017/10/1

Y1 - 2017/10/1

N2 - BACKGROUND: Despite a rise in the prevalence of hepatocellular carcinoma (HCC), data on HCC-related hospitalizations and financial burden are limited. The aim of this study was to evaluate temporal trends of HCC-related hospitalizations and evaluate its financial influence.MATERIALS AND METHODS: Patients with the diagnosis of HCC, as reported by International Classification of Diseases-Ninth Revision code, were identified from the National Inpatient Sample databases from 2002-2011. The national estimates of hospitalizations were derived using appropriate sample weights. The change in total average charges per each hospitalization over the study period was calculated after adjusting for inflation.RESULTS: Hospitalizations related to HCC have increased from 24,024 in 2002 to 50,609 in 2011. Of these admissions, HCC was the principal diagnosis in 10,762 and 16,350 subjects in 2002 and 2011, respectively. Most were white males (male: 70%; white: 55%). The overall inpatient mortality was significantly decreased from 13.5% in 2002 to 9.9% in 2011 (P < 0.01). The same trend was also observed for the length of hospital stay (6.5 versus 5.6 days in 2002 and 2011, respectively). The inflation-adjusted cost per hospitalization increased by approximately 47% during the study period.CONCLUSIONS: Despite the decrease in mortality rate and length-of-stay, hospitalizations and financial burden associated with HCC continued to increase between 2002 and 2011 in the United States.

AB - BACKGROUND: Despite a rise in the prevalence of hepatocellular carcinoma (HCC), data on HCC-related hospitalizations and financial burden are limited. The aim of this study was to evaluate temporal trends of HCC-related hospitalizations and evaluate its financial influence.MATERIALS AND METHODS: Patients with the diagnosis of HCC, as reported by International Classification of Diseases-Ninth Revision code, were identified from the National Inpatient Sample databases from 2002-2011. The national estimates of hospitalizations were derived using appropriate sample weights. The change in total average charges per each hospitalization over the study period was calculated after adjusting for inflation.RESULTS: Hospitalizations related to HCC have increased from 24,024 in 2002 to 50,609 in 2011. Of these admissions, HCC was the principal diagnosis in 10,762 and 16,350 subjects in 2002 and 2011, respectively. Most were white males (male: 70%; white: 55%). The overall inpatient mortality was significantly decreased from 13.5% in 2002 to 9.9% in 2011 (P < 0.01). The same trend was also observed for the length of hospital stay (6.5 versus 5.6 days in 2002 and 2011, respectively). The inflation-adjusted cost per hospitalization increased by approximately 47% during the study period.CONCLUSIONS: Despite the decrease in mortality rate and length-of-stay, hospitalizations and financial burden associated with HCC continued to increase between 2002 and 2011 in the United States.

KW - Financial burden

KW - Hepatocellular carcinoma

KW - Hospitalizations

KW - Liver cancer

KW - National Inpatient Sample database

UR - http://www.scopus.com/inward/record.url?scp=85032701448&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032701448&partnerID=8YFLogxK

U2 - 10.1016/j.amjms.2017.05.016

DO - 10.1016/j.amjms.2017.05.016

M3 - Article

VL - 354

SP - 362

EP - 369

JO - American Journal of the Medical Sciences

JF - American Journal of the Medical Sciences

SN - 0002-9629

IS - 4

ER -